Celldex Therapeutics
CLDX
CLDX
129 hedge funds and large institutions have $204M invested in Celldex Therapeutics in 2017 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 44 increasing their positions, 29 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.17% less ownership
Funds ownership: 3.88% → 3.71% (-0.17%)
1% less funds holding
Funds holding: 130 → 129 (-1)
Holders
129
Holding in Top 10
2
Calls
$904K
Puts
$837K
Top Buyers
| 1 | +$4.82M | |
| 2 | +$3.63M | |
| 3 | +$3.31M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.05M |
| 5 |
MG
Meditor Group
Hamilton,
Bermuda
|
+$1.47M |
Top Sellers
| 1 | -$9.52M | |
| 2 | -$6.02M | |
| 3 | -$3.56M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.32M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.16M |